From: The direction of cross affects obesity after puberty in male but not female offspring
Gene Symbol1 | Chr | Gene description | Mean RPKM2 | Fch matBFMI/ | t Test P-value | TFBS3 | |
---|---|---|---|---|---|---|---|
patBFMI | matBFMI | patBFMI | |||||
Slc16a7 | 10 | solute carrier family 16 (monocarboxylic acid transp.), 7 | 1.91 | 2.30 | 1.20 | 0.0007 | Esrrb |
Nlrp12 | 7 | NLR family, pyrin domain containing 12 | 2.66 | 2.19 | 0.82 | 0.0009 | ERE |
Il1r1 | 1 | interleukin 1 receptor, type I | 2.16 | 1.60 | 0.74 | 0.0019 | - |
St5 | 7 | suppression of tumorigenicity 5 | 1.97 | 1.61 | 0.82 | 0.0029 | - |
Hmgcr | 13 | 3-hydroxy-3-methylglutaryl-Coenzyme A reductase | 3.01 | 3.98 | 1.32 | 0.0034 | - |
Scara5 | 14 | scavenger receptor class A, member 5 (putative) | 1.23 | 0.55 | 0.44 | 0.0050 | - |
Gpr110 | 17 | G protein-coupled receptor 110 | 1.48 | 0.85 | 0.57 | 0.0092 | - |
Grem2 | 1 | gremlin 2 homolog, cysteine knot superfamily | 1.50 | 1.11 | 0.74 | 0.0102 | - |
Fasn | 11 | fatty acid synthase | 4.47 | 5.41 | 1.21 | 0.0110 | ERE |
Selenbp2 | 3 | selenium binding protein 2 | 5.72 | 4.76 | 0.83 | 0.0113 | - |
Cyp4a14 | 4 | cytochrome P450, family 4, subfam. a, polypept. 14 | 3.58 | 4.74 | 1.32 | 0.0119 | - |
Cyp2c38 | 19 | cytochrome P450, family 2, subfamily c, polypet. 38 | 1.46 | 2.33 | 1.60 | 0.0122 | Esrra, Esrrb |
Crat | 2 | carnitine acetyltransferase | 1.79 | 2.27 | 1.26 | 0.0128 | - |
Coq10b | 1 | coenzyme Q10 homolog B (S. cerevisiae) | 1.42 | 1.98 | 1.39 | 0.0138 | - |
Rai14 | 15 | retinoic acid induced 14 | 1.98 | 1.64 | 0.83 | 0.0144 | - |
Mup-ps20 | 4 | major urinary protein, pseudogene 20 | 1.46 | 0.51 | 0.35 | 0.0145 | - |
Arntl | 7 | aryl hydrocarbon receptor nuclear translocator-like | 1.90 | 1.05 | 0.55 | 0.0151 | - |
Acnat2 | 4 | acyl-coenzyme A amino acid N-acyltransferase 2 | 2.37 | 3.22 | 1.36 | 0.0155 | Esrrb, IR3 |
Abcd2 | 15 | ATP-binding cassette, sub-family D (ALD), 2 | 1.14 | 1.72 | 1.51 | 0.0157 | - |
Cyp2c39 | 19 | cytochrome P450, family 2, subfamily c, polypept.39 | 2.77 | 3.57 | 1.29 | 0.0157 | Esrra, Esrrb |
Slc45a3 | 1 | solute carrier family 45, member 3 | 2.15 | 1.72 | 0.80 | 0.0166 | - |
Sntg2 | 12 | syntrophin, gamma 2 | 1.75 | 1.45 | 0.83 | 0.0187 | - |
Per2 | 1 | period circadian clock 2 | 1.26 | 1.67 | 1.32 | 0.0208 | - |
Hcn3 | 3 | hyperpolarization-activated, cyclic nucleotide-gated | 0.95 | 1.51 | 1.60 | 0.0208 | - |
Gas6 | 8 | growth arrest specific 6 | 2.26 | 2.73 | 1.21 | 0.0209 | - |
Serpina12 | 12 | ser/cys peptidase inhibitor, member 12 | 2.40 | 1.94 | 0.81 | 0.0211 | - |
Elovl6 | 3 | ELOVL family member 6, elongation of LCFA | 3.20 | 4.17 | 1.30 | 0.0214 | - |
Acsl3 | 1 | acyl-CoA synthetase long-chain family member 3 | 2.24 | 2.71 | 1.21 | 0.0215 | - |
Acot4 | 12 | acyl-CoA thioesterase 4 | 0.93 | 1.66 | 1.79 | 0.0219 | - |
Slc20a1 | 2 | solute carrier family 20, member 1 | 1.54 | 1.87 | 1.21 | 0.0219 | - |
B3galt1 | 2 | UDP beta 1,3-galactosyltransferase, polypept.1 | 1.52 | 1.07 | 0.70 | 0.0230 | - |
Cyp7b1 | 3 | cytochrome P450, family 7, subfamily b, polypept. 1 | 5.11 | 4.23 | 0.83 | 0.0257 | - |
Cyp4a10 | 4 | cytochrome P450, family 4, subfamily a, polypept.10 | 3.78 | 5.02 | 1.33 | 0.0260 | ERE, IR3 |